Prostaglandin E2 has antinociceptive effect through EP1 receptor in the ventromedial hypothalamus in rats

Masako Hosoi, Takakazu Oka, Michie Abe, Tetsuro Hori, Hiroshi Yamamoto, Kazunori Mine, Chiharu Kubo

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The effects of microinjection of prostaglandin E2 (PGE2) (50 fg-50 ng/0.2 μl) into the ventromedial hypothalamus (VMH) on nociception were studied using a hot-plate test in rats. Microinjection of PGE2 (5-500 pg and 50 ng/0.2 μl) into the VMH significantly prolonged the paw-withdrawal latency on a hot plate 5 and 10 min after injection, respectively. Maximal prolongation was obtained 5 min after the injection of PGE2 at 5 pg. Subsequently, to determine whether the PGE2 receptor subtype EP1 is involved in the PGE2-induced antinociceptive effect in the VMH, we observed the changes in nociception after intraVMH microinjection of SC19220, an EP1 receptor antagonist, and 17-phenyl-ω-trinor PGE2, an EP1 receptor agonist. Simultaneous injection of SC19220 (150 ng) with PGE2 (500 pg) into the VMH blocked the PGE2-induced prolongation of the paw-withdrawal latency. Moreover, an intraVMH microinjection of 17-phenyl-ω-trinor PGE2 (500 pg) prolonged it. These results indicate that PGE2 in the VMH has antinociceptive effect through its actions on EP1 receptors in rats. Copyright (C) 1999 International Association for the Study of Pain. Published by Elsevier Science B.V.

Original languageEnglish
Pages (from-to)221-227
Number of pages7
JournalPain
Volume83
Issue number2
DOIs
Publication statusPublished - Nov 1 1999

Fingerprint

Dinoprostone
Hypothalamus
Microinjections
Nociception
Injections
Receptors, Prostaglandin E, EP1 Subtype

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Prostaglandin E2 has antinociceptive effect through EP1 receptor in the ventromedial hypothalamus in rats. / Hosoi, Masako; Oka, Takakazu; Abe, Michie; Hori, Tetsuro; Yamamoto, Hiroshi; Mine, Kazunori; Kubo, Chiharu.

In: Pain, Vol. 83, No. 2, 01.11.1999, p. 221-227.

Research output: Contribution to journalArticle

Hosoi, Masako ; Oka, Takakazu ; Abe, Michie ; Hori, Tetsuro ; Yamamoto, Hiroshi ; Mine, Kazunori ; Kubo, Chiharu. / Prostaglandin E2 has antinociceptive effect through EP1 receptor in the ventromedial hypothalamus in rats. In: Pain. 1999 ; Vol. 83, No. 2. pp. 221-227.
@article{cc258aed562b4377b392d051108c28b7,
title = "Prostaglandin E2 has antinociceptive effect through EP1 receptor in the ventromedial hypothalamus in rats",
abstract = "The effects of microinjection of prostaglandin E2 (PGE2) (50 fg-50 ng/0.2 μl) into the ventromedial hypothalamus (VMH) on nociception were studied using a hot-plate test in rats. Microinjection of PGE2 (5-500 pg and 50 ng/0.2 μl) into the VMH significantly prolonged the paw-withdrawal latency on a hot plate 5 and 10 min after injection, respectively. Maximal prolongation was obtained 5 min after the injection of PGE2 at 5 pg. Subsequently, to determine whether the PGE2 receptor subtype EP1 is involved in the PGE2-induced antinociceptive effect in the VMH, we observed the changes in nociception after intraVMH microinjection of SC19220, an EP1 receptor antagonist, and 17-phenyl-ω-trinor PGE2, an EP1 receptor agonist. Simultaneous injection of SC19220 (150 ng) with PGE2 (500 pg) into the VMH blocked the PGE2-induced prolongation of the paw-withdrawal latency. Moreover, an intraVMH microinjection of 17-phenyl-ω-trinor PGE2 (500 pg) prolonged it. These results indicate that PGE2 in the VMH has antinociceptive effect through its actions on EP1 receptors in rats. Copyright (C) 1999 International Association for the Study of Pain. Published by Elsevier Science B.V.",
author = "Masako Hosoi and Takakazu Oka and Michie Abe and Tetsuro Hori and Hiroshi Yamamoto and Kazunori Mine and Chiharu Kubo",
year = "1999",
month = "11",
day = "1",
doi = "10.1016/S0304-3959(99)00105-0",
language = "English",
volume = "83",
pages = "221--227",
journal = "Pain",
issn = "0304-3959",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Prostaglandin E2 has antinociceptive effect through EP1 receptor in the ventromedial hypothalamus in rats

AU - Hosoi, Masako

AU - Oka, Takakazu

AU - Abe, Michie

AU - Hori, Tetsuro

AU - Yamamoto, Hiroshi

AU - Mine, Kazunori

AU - Kubo, Chiharu

PY - 1999/11/1

Y1 - 1999/11/1

N2 - The effects of microinjection of prostaglandin E2 (PGE2) (50 fg-50 ng/0.2 μl) into the ventromedial hypothalamus (VMH) on nociception were studied using a hot-plate test in rats. Microinjection of PGE2 (5-500 pg and 50 ng/0.2 μl) into the VMH significantly prolonged the paw-withdrawal latency on a hot plate 5 and 10 min after injection, respectively. Maximal prolongation was obtained 5 min after the injection of PGE2 at 5 pg. Subsequently, to determine whether the PGE2 receptor subtype EP1 is involved in the PGE2-induced antinociceptive effect in the VMH, we observed the changes in nociception after intraVMH microinjection of SC19220, an EP1 receptor antagonist, and 17-phenyl-ω-trinor PGE2, an EP1 receptor agonist. Simultaneous injection of SC19220 (150 ng) with PGE2 (500 pg) into the VMH blocked the PGE2-induced prolongation of the paw-withdrawal latency. Moreover, an intraVMH microinjection of 17-phenyl-ω-trinor PGE2 (500 pg) prolonged it. These results indicate that PGE2 in the VMH has antinociceptive effect through its actions on EP1 receptors in rats. Copyright (C) 1999 International Association for the Study of Pain. Published by Elsevier Science B.V.

AB - The effects of microinjection of prostaglandin E2 (PGE2) (50 fg-50 ng/0.2 μl) into the ventromedial hypothalamus (VMH) on nociception were studied using a hot-plate test in rats. Microinjection of PGE2 (5-500 pg and 50 ng/0.2 μl) into the VMH significantly prolonged the paw-withdrawal latency on a hot plate 5 and 10 min after injection, respectively. Maximal prolongation was obtained 5 min after the injection of PGE2 at 5 pg. Subsequently, to determine whether the PGE2 receptor subtype EP1 is involved in the PGE2-induced antinociceptive effect in the VMH, we observed the changes in nociception after intraVMH microinjection of SC19220, an EP1 receptor antagonist, and 17-phenyl-ω-trinor PGE2, an EP1 receptor agonist. Simultaneous injection of SC19220 (150 ng) with PGE2 (500 pg) into the VMH blocked the PGE2-induced prolongation of the paw-withdrawal latency. Moreover, an intraVMH microinjection of 17-phenyl-ω-trinor PGE2 (500 pg) prolonged it. These results indicate that PGE2 in the VMH has antinociceptive effect through its actions on EP1 receptors in rats. Copyright (C) 1999 International Association for the Study of Pain. Published by Elsevier Science B.V.

UR - http://www.scopus.com/inward/record.url?scp=0032882250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032882250&partnerID=8YFLogxK

U2 - 10.1016/S0304-3959(99)00105-0

DO - 10.1016/S0304-3959(99)00105-0

M3 - Article

C2 - 10534593

AN - SCOPUS:0032882250

VL - 83

SP - 221

EP - 227

JO - Pain

JF - Pain

SN - 0304-3959

IS - 2

ER -